Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Term Outcomes After Drug-Induced Liver Injury
Paul H. Hayashi, Einar S. Björnsson
Current Hepatology Reports (2018) Vol. 17, Iss. 3, pp. 292-299
Open Access | Times Cited: 20

Showing 20 citing articles:

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
Rolf Teschke, Gaby Danan
Medicines (2020) Vol. 7, Iss. 10, pp. 62-62
Open Access | Times Cited: 74
Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective
Jyoti Rani, Sanju Bala Dhull, Pawan Kumar Rose, et al.
Phytomedicine (2023) Vol. 122, pp. 155142-155142
Closed Access | Times Cited: 28
Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
Rolf Teschke
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 70
Mechanism of drug-induced liver injury and hepatoprotective effects of natural drugs
Yongfeng Zhou, Junnan Wang, Dingkun Zhang, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 41
Hepatotoxicity from long-term administration of hepatoprotective low doses of oleanolic acid in mice
Ya-Sha Xu, Yang Xi, Yuan‐Fu Lu, et al.
Toxicology and Applied Pharmacology (2025) Vol. 497, pp. 117277-117277
Closed Access
Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI
Kristin Ashby, Wei Vivian Zhuang, A. González-Jiménez, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 333-341
Open Access | Times Cited: 31
Psoralen induces hepatic toxicity through PERK and ATF6 related ER stress pathways in HepG2 cells
Yingli Yu, Ruili Yu, Wei‐jie Men, et al.
Toxicology Mechanisms and Methods (2019) Vol. 30, Iss. 1, pp. 39-47
Closed Access | Times Cited: 31
The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
Wenhui Liu, Xiangchang Zeng, Yating Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Drug-induced liver injury
Jeong Ill Suh
Yeungnam university journal of medicine (2019) Vol. 37, Iss. 1, pp. 2-12
Open Access | Times Cited: 29
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics
Fernando Bessone, Nelia Hernández, Mario Tanno, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 03, pp. 331-348
Closed Access | Times Cited: 19
An adaptable soft-mold embossing process for fabricating optically-accessible, microfeature-based culture systems and application toward liver stage antimalarial compound testing
Steven P. Maher, Amy J. Conway, Alison Roth, et al.
Lab on a Chip (2020) Vol. 20, Iss. 6, pp. 1124-1139
Open Access | Times Cited: 18
Idiosyncratic DILI and RUCAM under One Hat: The Global View
Rolf Teschke, Gaby Danan
Livers (2023) Vol. 3, Iss. 3, pp. 397-433
Open Access | Times Cited: 6
Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress
Shin-Lun Wu, Chih‐Ning Cheng, Chi‐Chuan Wang, et al.
Toxicology and Applied Pharmacology (2020) Vol. 403, pp. 115157-115157
Closed Access | Times Cited: 10
The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury
Tingting He, Lutong Ren, Man Gong, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 10, pp. 102009-102009
Open Access | Times Cited: 6
The native liver as inspiration to create superior in vitro hepatic models
Nathan Carpentier, Luca Urbani, Peter Dubruel, et al.
Biomaterials Science (2023) Vol. 11, Iss. 4, pp. 1091-1115
Open Access | Times Cited: 3
Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach
A. González-Jiménez, Ayako Suzuki, Minjun Chen, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 5, pp. 1793-1803
Open Access | Times Cited: 5
Integrated metabolomics, network pharmacology, and molecular docking to reveal the mechanisms of Isodon excisoides against drug‐induced liver injury
Xinming Jia, Shilin Sun, Mengxin Yang, et al.
Biomedical Chromatography (2023) Vol. 37, Iss. 9
Closed Access | Times Cited: 1
Regional and Racial Differences in Drug-Induced Liver Injury
Paul H. Hayashi
Current Hepatology Reports (2019) Vol. 18, Iss. 3, pp. 280-286
Closed Access | Times Cited: 1
Drug-Induced Liver Injury in Older Adults
Ethan Miller, Hamzah Abu‐Sbeih, Naga Chalasani
Springer eBooks (2019), pp. 1-16
Closed Access | Times Cited: 1
Drug-Induced Liver Injury in Older Adults
Ethan Miller, Hamzah Abu‐Sbeih, Naga Chalasani
Springer eBooks (2021), pp. 1391-1406
Closed Access | Times Cited: 1
Page 1

Scroll to top